The National Institute on Drug Abuse awarded a firm fixed price contract valued at $8,939,640.00 to Booz Allen Hamilton Inc. to provide a National Institute on Drug Abuse Developmental Studies Biorepository and Analysis Center from September 17, 2022 through September 16, 2023. Booz Allen Hamilton will subcontract with Infinity Biologix LLC D.b.a. Sampled Division to provide a biorepository and perform certain metabolic, hematologic, and other assays, and cutting-edge, high throughput genotyping, sequencing, and gene-expression in CLIA-certified laboratories. An additional subcontract was awarded to United State Drug Testing Laboratories, Inc. to perform toxicology analysis of biological tissues and fluids in support of this effort.
Generated 11/28/23, 12:32 AM